Natalizumab therapy for moderate to severe Crohn disease in adolescents (Q34606609)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Natalizumab therapy for moderate to severe Crohn disease in adolescents
scientific article

    Statements

    Natalizumab therapy for moderate to severe Crohn disease in adolescents (English)
    Jeffrey S Hyams
    David C Wilson
    Adrian Thomas
    Robert Heuschkel
    Sally Mitton
    Brent Mitchell
    Regina Daniels
    Michele A Libonati
    Susan Zanker
    International Natalizumab CD305 Trial Group
    1 February 2007

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit